Experts Identified Steps to Manage Psoriasis Treatment Failure
If your psoriasis therapy seems to be losing its effectiveness, these diagnostic steps can help your doctor determine the cause.
Updated on Sept. 24, 2026 in Heart Disease
Live Poll
Should patients investigate treatment adherence before assuming their medication has stopped working?
Dermatology experts have outlined a clinical framework to evaluate why psoriasis treatments sometimes fail. This approach helps clinicians distinguish between drug inefficacy and factors like dosing issues or incorrect diagnoses.
Why it matters
Understanding the specific cause of treatment failure is critical for ensuring patients receive the right therapy rather than unnecessarily switching medications. This methodical evaluation process helps clinicians address logistical or diagnostic barriers that might be mistaken for drug resistance.
A Brazilian study of 166 patients identified significant logistics-related discontinuation, while separate research showed 82.6% of patients achieved PASI-75 three months after switching between specific biologic inhibitors.
The players
Brazilian Congress of Dermatology
A major professional organization dedicated to advancing skin health and dermatological research.
The details
Clinicians are now focusing on distinguishing between primary treatment failure, where no response occurs, and secondary failure, where a patient stops responding over time. The diagnostic process involves checking for adherence issues, dispensing interruptions, and potential antidrug antibodies that can neutralize a treatment. Experts also emphasize verifying that symptoms are truly inflammatory, as structural damage from psoriatic arthritis can sometimes mimic active disease.
Timeline
September 10, 2026: Dermatology forum held in Fortaleza, Brazil.
January 2015 to June 2025: Data collection period for the BIOREP registry.
Health Landscape
The use of long-term registries like the BIOREP registry has become the standard for tracking how biologic therapies perform in real-world settings. This data helps medical experts move beyond initial clinical trial results to understand the complexities of long-term adherence and secondary drug failure.
If you are concerned that your psoriasis medication is not working as expected, talk to your doctor about whether your treatment issues might be related to dosing frequency or dispensing logistics. It is worth asking if antibody testing or a clinical review could help identify why your response has changed.
The takeaway
Psoriasis treatment success often depends on identifying whether a lack of response is due to biological changes or external factors. Patients should consult their dermatologist to rule out adherence, dosing, or diagnostic issues before concluding that a medication is no longer effective.
Further reading
For more on managing long-term treatment responses for complex conditions, visit Heart Disease.
Source note: This article includes information reported by Medscape.
Live Poll
Should patients investigate treatment adherence before assuming their medication has stopped working?
